Alprolix®

Active substance

Eftrenacog alfa

Holder

Sobi Belgium

Status

Closed

Indication

Treatment and prophylaxis of bleedings in hemophilia B patients (deficiency= Factor IX coagulation factor)

Public documents

Approbation

Information for the patient

Informed consent

Last update

17/01/2018

Last updated on 13/02/2024